| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 2,509,058 | 2,566,134 | 2,313,971 | 2,557,989 | | Cost of Revenue | 2,245,068 | 2,287,388 | 2,066,017 | 2,268,147 | | | Gross Profit | 263,990 | 278,746 | 247,954 | 289,842 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 231,608 | 215,675 | 205,132 | 201,930 | | Non Recurring | 1,954 | 3,793 | 1,569 | 2,059 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,428 | 59,278 | 41,253 | 85,853 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 57 | | Earnings Before Interest And Taxes | 30,052 | 59,278 | 41,253 | 85,910 | | Interest Expense | (251) | 116 | 135 | 86 | | Income Before Tax | 30,303 | 59,162 | 41,118 | 85,824 | | Income Tax Expense | 12,529 | 23,991 | 16,694 | 33,017 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,774 | 35,171 | 24,424 | 52,807 | | | Non-recurring Events | | Discontinued Operations | (104) | (106) | (88) | (148) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,670 | 35,065 | 24,336 | 52,659 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,670 | $35,065 | $24,336 | $52,659 |
|
0.67% Nasdaq 
Income Statement
